KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Net Income (2019 - 2025)

GoodRx Holdings (GDRX) has disclosed Net Income for 7 consecutive years, with $5.4 million as the latest value for Q4 2025.

  • Quarterly Net Income fell 19.51% to $5.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $30.4 million through Dec 2025, up 85.72% year-over-year, with the annual reading at $30.4 million for FY2025, 85.72% up from the prior year.
  • Net Income hit $5.4 million in Q4 2025 for GoodRx Holdings, up from $1.1 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $58.8 million in Q2 2023 to a low of -$41.7 million in Q3 2022.
  • Historically, Net Income has averaged -$1.0 million across 5 years, with a median of $1.4 million in 2021.
  • Biggest YoY gain for Net Income was 4254.49% in 2023; the steepest drop was 1211.82% in 2023.
  • Year by year, Net Income stood at -$39.9 million in 2021, then skyrocketed by 95.06% to -$2.0 million in 2022, then plummeted by 1211.82% to -$25.9 million in 2023, then surged by 126.05% to $6.7 million in 2024, then dropped by 19.51% to $5.4 million in 2025.
  • Business Quant data shows Net Income for GDRX at $5.4 million in Q4 2025, $1.1 million in Q3 2025, and $12.8 million in Q2 2025.